Oncogenic Activation of the RNA Binding Protein NELFE and MYC Signaling in Hepatocellular Carcinoma

Adelman, 2012, Promoter-proximal pausing of RNA polymerase II: emerging roles in metazoans, Nat. Rev. Genet., 13, 720, 10.1038/nrg3293

Auerbach, 2013, Relating genes to function: identifying enriched transcription factors using the ENCODE ChIP-Seq significance tool, Bioinformatics, 29, 1922, 10.1093/bioinformatics/btt316

Beer, 2004, Developmental context determines latency of MYC-induced tumorigenesis, PLoS Biol., 2, e332, 10.1371/journal.pbio.0020332

Boyault, 2007, Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets, Hepatology, 45, 42, 10.1002/hep.21467

Busa, 2007, The RNA-binding protein Sam68 contributes to proliferation and survival of human prostate cancer cells, Oncogene, 26, 4372, 10.1038/sj.onc.1210224

Castello, 2012, Insights into RNA biology from an atlas of mammalian mRNA-binding proteins, Cell, 149, 1393, 10.1016/j.cell.2012.04.031

Castello, 2013, RNA-binding proteins in Mendelian disease, Trends Genet., 29, 318, 10.1016/j.tig.2013.01.004

Chan, 2004, High-throughput tissue microarray analysis of c-myc activation in chronic liver diseases and hepatocellular carcinoma, Hum. Pathol., 35, 1324, 10.1016/j.humpath.2004.06.012

Chen, 2002, Gene expression patterns in human liver cancers, Mol. Biol. Cell, 13, 1929, 10.1091/mbc.02-02-0023

Chen, 2013, Recoding RNA editing of AZIN1 predisposes to hepatocellular carcinoma, Nat. Med., 19, 209, 10.1038/nm.3043

Dang, 2012, MYC on the path to cancer, Cell, 149, 22, 10.1016/j.cell.2012.03.003

Delmore, 2011, BET bromodomain inhibition as a therapeutic strategy to target c-Myc, Cell, 146, 904, 10.1016/j.cell.2011.08.017

El-Serag, 2011, Hepatocellular carcinoma, N. Engl. J. Med., 365, 1118, 10.1056/NEJMra1001683

Gabay, 2014, MYC activation is a hallmark of cancer initiation and maintenance, Cold Spring Harb. Perspect. Med., 4, 10.1101/cshperspect.a014241

Gerstberger, 2014, A census of human RNA-binding proteins, Nat. Rev. Genet., 15, 829, 10.1038/nrg3813

Hahn, 2002, Rules for making human tumor cells, N. Engl. J. Med., 347, 1593, 10.1056/NEJMra021902

Han, 2013, RNA-binding protein PCBP2 modulates glioma growth by regulating FHL3, J. Clin. Invest., 123, 2103, 10.1172/JCI61820

Hanahan, 2011, Hallmarks of cancer: the next generation, Cell, 144, 646, 10.1016/j.cell.2011.02.013

Iida, 2012, Overexpression of the RD RNA binding protein in hepatitis C virus-related hepatocellular carcinoma, Oncol. Rep., 28, 728, 10.3892/or.2012.1821

Jiang, 2010, Cooperation of tumor-derived HBx mutants and p53-249(ser) mutant in regulating cell proliferation, anchorage-independent growth and aneuploidy in a telomerase-immortalized normal human hepatocyte-derived cell line, Int. J. Cancer, 127, 1011, 10.1002/ijc.25118

Kaposi-Novak, 2009, Central role of c-Myc during malignant conversion in human hepatocarcinogenesis, Cancer Res., 69, 2775, 10.1158/0008-5472.CAN-08-3357

Katz, 2012, Disruption of Trp53 in livers of mice induces formation of carcinomas with bilineal differentiation, Gastroenterology, 142, 1229, 10.1053/j.gastro.2012.02.009

Kechavarzi, 2014, Dissecting the expression landscape of RNA-binding proteins in human cancers, Genome Biol., 15, R14, 10.1186/gb-2014-15-1-r14

Kim, 2013, Mutations in prion-like domains in hnRNPA2B1 and hnRNPA1 cause multisystem proteinopathy and ALS, Nature, 495, 467, 10.1038/nature11922

Lee, 2004, Classification and prediction of survival in hepatocellular carcinoma by gene expression profiling, Hepatology, 40, 667, 10.1002/hep.20375

Lee, 2006, A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells, Nat. Med., 12, 410, 10.1038/nm1377

Lowe, 2004, Intrinsic tumour suppression, Nature, 432, 307, 10.1038/nature03098

Lukong, 2008, RNA-binding proteins in human genetic disease, Trends Genet., 24, 416, 10.1016/j.tig.2008.05.004

Mittal, 2009, Dissecting the expression dynamics of RNA-binding proteins in posttranscriptional regulatory networks, Proc. Natl. Acad. Sci. USA, 106, 20300, 10.1073/pnas.0906940106

Nguyen, 2014, Lin28b is sufficient to drive liver cancer and necessary for its maintenance in murine models, Cancer Cell, 26, 248, 10.1016/j.ccr.2014.06.018

Ortiz-Zapater, 2012, Key contribution of CPEB4-mediated translational control to cancer progression, Nat. Med., 18, 83, 10.1038/nm.2540

Rahl, 2010, c-Myc regulates transcriptional pause release, Cell, 141, 432, 10.1016/j.cell.2010.03.030

Ray, 2009, Rapid and systematic analysis of the RNA recognition specificities of RNA-binding proteins, Nat. Biotechnol., 27, 667, 10.1038/nbt.1550

Ray, 2013, A compendium of RNA-binding motifs for decoding gene regulation, Nature, 499, 172, 10.1038/nature12311

Roessler, 2010, A unique metastasis gene signature enables prediction of tumor relapse in early-stage hepatocellular carcinoma patients, Cancer Res., 70, 10202, 10.1158/0008-5472.CAN-10-2607

Roessler, 2012, Integrative genomic identification of genes on 8p associated with hepatocellular carcinoma progression and patient survival, Gastroenterology, 142, 957, 10.1053/j.gastro.2011.12.039

Shachaf, 2004, MYC inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancer, Nature, 431, 1112, 10.1038/nature03043

Takai, 2016, Three-dimensional organotypic culture models of human hepatocellular carcinoma, Sci. Rep., 6, 21174, 10.1038/srep21174

Teufel, 2012, Snapshot liver transcriptome in hepatocellular carcinoma, J. Hepatol., 56, 990, 10.1016/j.jhep.2011.08.024

Theise, 2014

Thorgeirsson, 2002, Molecular pathogenesis of human hepatocellular carcinoma, Nat. Genet., 31, 339, 10.1038/ng0802-339

Vogelstein, 2013, Cancer genome landscapes, Science, 339, 1546, 10.1126/science.1235122

Wang, 2007, Improved low molecular weight Myc-Max inhibitors, Mol. Cancer Ther., 6, 2399, 10.1158/1535-7163.MCT-07-0005

Wang, 2012, MicroRNAs in liver disease, Gastroenterology, 142, 1431, 10.1053/j.gastro.2012.04.007

Wurth, 2012, Versatility of RNA-binding proteins in cancer, Comp. Funct. Genomics, 2012, 178525, 10.1155/2012/178525

Yin, 2003, Low molecular weight inhibitors of Myc-Max interaction and function, Oncogene, 22, 6151, 10.1038/sj.onc.1206641

Zhu, 2014, TCGA-assembler: open-source software for retrieving and processing TCGA data, Nat. Methods, 11, 599, 10.1038/nmeth.2956